Prospective Trial Using Gastric Stapling Line Reinforcement With Seamguard in Roux-en-Y Gastric Bypass
Laparoscopic Roux-en-Y Gastric Bypass Outcomes With Systematic Gastric Stapling Line Reinforcement With Seamguard Biomaterial
1 other identifier
interventional
80
1 country
1
Brief Summary
Study objectives : Primary endpoint is to a assess the change in blood loss (originating from stapling the stomach) with the use of Seamguard reinforcement Secondary endpoint is to evaluate the difference in leak rate Methods : Prospective. Randomized study. Published data does not allow for clear determination of the number of patients required for the study. Based on our own experience. The investigators estimate that the average postoperative blood loss is 200ml with a standard deviation of 100ml over 3 days. Based on this assumption. A total number of patients (control + Seamguard groups) of 60 is required if the expected reduction of the mean drainage volume is 100ml and 82 patients for an expected drainage volume reduction of 85ml. All patients candidates to a laparoscopic gastric bypass will be enrolled in the study Under the conditions this is a primary bariatric procedure (no revision allowed)., no history of hiatal surgery such as anti-reflux nor significant upper abdominal surgery. The only associated surgical procedure allowed is the cholecystectomy. Patients' inclusion : Will be done immediately before surgical procedure following acceptance of a written consent. Bleeding from liver or slpeen injury will lead to patient's exclusion. Methods : Surgical procedures are identical for the 2 surgeons of the study (GB and PT) with 30-50ml gastric pouch. Linear. side to side. Antegastric and antecolic gastrojejunal anstomosis . Use of Echelon 60 linear stapler with GOLD cartridges on stomach. Blue to perform the gastrojejunal anastomosis and white on Small bowel. Peroperativeblood loss and need to apply clips or stitches on the gastric staple line are recorded. Operation time and patient information (BMI. Comorbidities) are recorded as well any noticeable or unexpected event. Postoperative blood loss is assessed by at least 1 abdominal closed circuit suction drain left for a minimum of 3 days (removal on postop day 3 at the earliest). In addition hemoglobin and red cell count is performed on postop day 1 and 2. Absence of leakage is confirmed by methylene blue test perop as well as on postop day 1 before resuming fluids and on postop day 2 by a gastrograffin swallow. Drinks and food are resumed according to the standard practice between postop day 1 and postop day 2. Duration of the hospital stay and postoperative course will be documented. Early follow up is clinically done at 1 month postop without any specific radiological or biological examination. Data collection Will be done on a form during and after the procedure BLOOD LOSS : peroperative volume as well as daily drainage output (postop day 1. 2 and 3) as well as the sum of the 3 postop days. Hemoglobin change is recorded on day 1 and 2. Need to leave drain(s) for more than 3 days is recorded. Study completion : Estimated time to complete the study based on the current experience is between 5 and 7 months. Sudy is closed 1 month after the last inclusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 5, 2009
CompletedFirst Posted
Study publicly available on registry
November 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJanuary 5, 2010
January 1, 2010
5 months
August 5, 2009
January 4, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood loss volume per and postoperatively, additional hemostatic measures peroperatively, hemoglobin levels postoperatively
3 days postoperatively
Secondary Outcomes (1)
gastrojejunal anastomosis leakage rate: clinical and radiological
postoperative day 2 (gastrograffin swallow)
Study Arms (2)
Standard stapling without reinforcement
ACTIVE COMPARATORStandard Echelon 60 linear stapling with GOLD cartridges
Seamguard gastric stapling line reinforcement
ACTIVE COMPARATORInterventions
Primary bariatric surgery. Standard laparoscopic procedure with linear stapling divising of the stomach (Echelon 60 stapler, GOLD cartridges) with or with Seamguard reinforcement
Eligibility Criteria
You may qualify if:
- all primary laparoscopic Roux-en-Y gastric bypasses for morbid obesity
You may not qualify if:
- additional procedures except cholecystectomy, peroperative bleeding from spleen or liver injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique de l'Anjou
Angers, 49044, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe A Topart, MD
Société de Chirurgie Viscérale
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 5, 2009
First Posted
November 18, 2009
Study Start
July 1, 2009
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
January 5, 2010
Record last verified: 2010-01